Search Results 2061-2070 of 19655 for Hemoglobin

1. A Study to Evaluate ORIN1001 in Idiopathic Pulmonary Fibrosis Subjects - Mayo Clinic

   - Hemoglobin <12.9 g/dL (men) and <11.9 g/dL (women). - Prothrombin time (PT) or partial thromboplastin time (PTT) >1.5 × upper limit of normal ...

2. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

   - Hemoglobin >= 90 g/L (9 g/dL) (obtained =< 28 days prior to randomization) - Subjects may be transfused to meet this criterion - Aspartate ...

3. Publications - Abhinav Khanna, M.D., M.P.H. - Mayo Clinic

   Hemoglobin A1c improvements and better diabetes-specific quality of life among participants completing diabetes self-management programs: a nested cohort ...

4. A Study to Evaluate Adjuvant Ado-Trastuzumab Emtansine (T-DM1) in HER2 Positive Breast Cancer - Mayo Clinic

   Hemoglobin >9.0 g/dL;; Total bilirubin ≤1.5 x upper limit of normal (ULN). If patient has known Gilbert's syndrome, direct bilirubin ≤2.0 x ULN;; AST and ...

5. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

   Hemoglobin (Hgb) >= 8 unless marrow was involved by CLL or RT, then Hgb >= 7 without transfusion =< 1 week prior to study registration (=< 14 days prior to ...

6. Phase 1 Study of Oral TP-1454 - Clinical Trials

   Hemoglobin ≥ 8 g/dL 10. Have acceptable coagulation status: 1. Patient has International Normalized Ratio (INR) or Prothrombin time (PT) ≤ 1.5 × ULN ...

7. A Study to Evaluate M7824 with Concurrent Chemoradiation (cCRT) in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

   Adequate hematological function defined by absolute neutrophil count (ANC) ≥ 1.5 × 10^9/L, platelet count ≥ 100 × 109/L, and hemoglobin ≥ 9 g/dL; ...

8. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

   Hemoglobin level ≤ 80 g/L (8.0 g/dL). Platelet count ≤ 100 × 10^9/L (100,000 cells/mm3) or ≥ 1000 × 10^9/L (1,000,000 cells/mm3).*; White blood cell count ...

9. A Study To Compare Standard Therapy To Treat Hodgkin Lymphoma To The Use Of Two Drugs, Brentuximab Vedotin And Nivolumab - Mayo Clinic

   ... hemoglobin by pulmonary function test (PFT) (within 7 days prior to enrollment). If unable to obtain PFTs, the criterion is: a pulse oximetry reading of ...

10. Low-Dose Selinexor and Choline Salicylate for the Treatment of Patients With Non-Hodgkin Lymphoma or Histiocytic/Dendritic Cell Neoplasms - Mayo Clinic

    - Hemoglobin >= 8.5 g/dL (may be transfused to reach criteria) (obtained =< 14 days prior to registration) - Total bilirubin < 2 x upper limit of normal ...